By Industry | By Industry Segment | By Services and Suppliers | By Location | By Hotbed | Profile Search

Company Profile


Radius Health 

950 Winter Street

Waltham  Massachusetts  02451  U.S.A.
Phone: 617-551-4000 Fax: 617-551-4701


Radius is a science-driven biopharmaceutical company focused on developing new therapeutics for patients with osteoporosis as well as other serious endocrine-mediated diseases.

Radius is committed to the research and development of new therapeutics for the large and underserved osteoporosis market.

Key Statistics

Ownership: Public

Web Site: Radius Health
Symbol: RDUS


Company News
Radius Health (RDUS) Appoints Former GlaxoSmithKline (GSK) CEO Jean-Pierre Garnier To Board Of Directors 12/8/2015 10:03:06 AM
Radius Health (RDUS) Announces Conference Call And Webcast On New Data For Investigational Drug RAD1901 To Be Presented At San Antonio Breast Cancer Symposium 2015 12/7/2015 11:47:11 AM
Radius Health (RDUS) Delays Osteoporosis Drug Application in the U.S. to Avoid Rush, Respect Staffers' Holidays 11/18/2015 6:03:54 AM
Radius Health (RDUS) Has Submitted A Marketing Authorization Application For The Investigational Drug Abaloparatide-SC For The Treatment Of Postmenopausal Osteoporosis In Europe 11/17/2015 11:35:59 AM
Radius Health (RDUS) To Host 2015 Investor Day On November 17th In New York City 11/13/2015 10:20:35 AM
Radius Health (RDUS) To Present At The Goldman, Sachs & Co. U.S. Emerging/SMID Cap Growth Conference 11/11/2015 10:25:58 AM
Radius Health (RDUS) Reports Third Quarter 2015 Financial And Operating Results 11/5/2015 11:26:37 AM
Radius Health (RDUS) To Present Promising Single-Agent Data For Investigational Oral Drug RAD1901 At 2015 American Association For Cancer ResearchNational Cancer InstituteEuropean Organization For Research And Treatment Of Cancer (AACR-NCI-EORTC) International Conference 11/2/2015 11:57:21 AM
While Baxalta (BXLT) Bid Simmers on the Back Burner, Shire (SHPG) Rumored to Be Eying Radius Health (RDUS) Acquisition 10/19/2015 6:27:21 AM
Radius Health (RDUS) Release: Investigational Drug Abaloparatide Reduces The Incidence Of Fractures In Postmenopausal Women With Osteoporosis 10/13/2015 7:40:33 AM